Robert Hariri J.'s most recent trade in CryoPort Inc was a trade of 5,000 Common Stock done at an average price of $8.6 . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 8.60 per share. | 22 Aug 2025 | 5,000 | 26,275 (0%) | 0% | 8.6 | 43,000 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 41,098 | 41,098 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 23,214 | 31,275 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 28 May 2025 | 12,500 | 8,061 (0%) | 0% | 6.1 | 76,250 | Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2025 | 3,281 | 21,482 | - | 0 | Class A Common Stock | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2025 | 3,281 | 3,281 | - | - | Restricted Stock Units | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2025 | 3,281 | 2,852,608 | - | 0 | Class A Common Stock | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2025 | 3,281 | 3,281 | - | - | Restricted Stock Units | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.64 per share. | 13 Apr 2025 | 1,154 | 20,328 | - | 1.6 | 1,893 | Class A Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.64 per share. | 13 Apr 2025 | 1,154 | 2,851,454 | - | 1.6 | 1,893 | Class A Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 6.48 per share. | 21 Nov 2024 | 2,500 | 20,561 (0%) | 0% | 6.5 | 16,200 | Common Stock |
| BioVie Inc | Robert J. Hariri | Director | 20 Nov 2024 | 49,800 | 49,800 | - | - | Stock Option (right to buy) | ||
| BioVie Inc | Robert J. Hariri | Director | 20 Nov 2024 | 21,815 | 21,815 | - | - | Stock Option (right to buy) | ||
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 9.46 per share. | 19 Aug 2024 | 1,000 | 23,061 (0%) | 0% | 9.5 | 9,465 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 14 Aug 2024 | 1,000 | 23,561 (0%) | 0% | 9 | 9,000 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 8.40 per share. | 14 Aug 2024 | 1,000 | 24,561 (0%) | 0% | 8.4 | 8,395 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 23,830 | 23,830 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 12,845 | 25,561 (0%) | 0% | 0 | Common Stock | |
| Celularity Inc Ordinary | Robert J. Hariri | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.11 per share. | 13 Apr 2024 | 1,154 | 2,855,889 | - | 4.1 | 4,743 | Class A Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 2,937,788 | 2,937,788 | - | - | Stock Option Grant (Right to Buy) | |
| CryoPort Inc | Robert Hariri J. | Director | Sale of securities on an exchange or to another person at price $ 16.89 per share. | 14 Dec 2023 | 800 | 12,716 (0%) | 0% | 16.9 | 13,512 | Common Stock |
| CryoPort Inc | J. Robert Hariri | Director | Sale of securities on an exchange or to another person at price $ 15.50 per share. | 11 Dec 2023 | 1,000 | 13,516 (0%) | 0% | 15.5 | 15,500 | Common Stock |
| BioVie Inc | Robert Hariri J. | Director | 09 Nov 2023 | 42,254 | 42,254 (0%) | 0% | 0 | Common Stock | ||
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 15,125 | 15,125 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 8,105 | 16,016 (0%) | 0% | 0 | Common Stock | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. | 13 Apr 2023 | 11,540 | 10,148,310 | - | 0.7 | 8,241 | Class A Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 2,084,854 | 2,084,854 | - | - | Warrants (Right to Buy) | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.83 per share. | 27 Mar 2023 | 2,084,854 | 10,159,850 | - | 0.8 | 1,739,394 | Class A Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 30 Nov 2022 | 10,000 | 8,074,996 | - | 1.7 | 17,175 | Class A Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 29 Nov 2022 | 40,000 | 8,064,996 | - | 1.7 | 68,400 | Class A Common Stock |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.74 per share. | 28 Nov 2022 | 40,000 | 8,024,996 | - | 1.7 | 69,600 | Class A Common Stock |
| BioVie Inc | Robert J. Hariri | Director | 23 Nov 2022 | 34,240 | 34,240 (0%) | 0% | 0 | COMMON STOCK | ||
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 119,073 | 230,287 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.87 per share. | 24 Aug 2022 | 119,073 | 7,984,996 | - | 2.9 | 341,740 | Class A Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Sale of securities on an exchange or to another person at price $ 43.29 per share. | 11 Aug 2022 | 2,000 | 7,911 (0%) | 0% | 43.3 | 86,581 | Common Stock |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 13,981 | 13,981 | - | - | Option (Right to Buy Common Stock) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 7,203 | 7,203 (0%) | 0% | 0 | Common Stock | |
| CryoPort Inc | Robert J. Hariri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 2,708 | 0 | - | - | Restricted Stock Rights | |
| CryoPort Inc | Robert J. Hariri | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 2,708 | 9,911 (0%) | 0% | - | Common Stock | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 384,801 | 384,801 | - | - | Stock Option (Right to Buy) | |
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 131,234 | 7,865,923 | - | - | Class A Common Stock | |
| BioVie Inc | Robert J. Hariri | Director | 05 Apr 2022 | 122,250 | 122,250 | - | - | Stock Option (right to buy) | ||
| Celularity Inc Ordinary | Robert J. Hariri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 2,690,079 | 2,690,079 | - | - | Stock Option (Right to Buy) | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 5,416 | 5,416 | - | - | Option to purchase common stock | |
| CryoPort Inc | Robert J. Hariri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 2,708 | 2,708 | - | - | Restricted Stock Rights |